News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
747,283 Results
Type
Article (43547)
Company Profile (281)
Press Release (703436)
Multimedia
Podcasts (98)
Webinars (21)
Section
Business (208755)
Career Advice (2066)
Deals (36060)
Drug Delivery (131)
Drug Development (83065)
Employer Resources (174)
FDA (16725)
Job Trends (15227)
News (353240)
Policy (33355)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2702)
Accelerated approval (47)
Adcomms (27)
Allergies (175)
Alliances (50699)
ALS (216)
Alzheimer's disease (1837)
Antibody-drug conjugate (ADC) (457)
Approvals (17104)
Artificial intelligence (714)
Autoimmune disease (296)
Automation (57)
Bankruptcy (367)
Best Places to Work (11811)
BIOSECURE Act (20)
Biosimilars (226)
Biotechnology (186)
Bladder cancer (189)
Brain cancer (74)
Breast cancer (759)
Cancer (5904)
Cardiovascular disease (479)
Career advice (1756)
Career pathing (43)
CAR-T (338)
CDC (56)
Celiac Disease (3)
Cell therapy (920)
Cervical cancer (47)
Clinical research (71866)
Collaboration (2127)
Company closure (5)
Compensation (1422)
Complete response letters (79)
COVID-19 (2792)
CRISPR (111)
C-suite (1154)
Cystic fibrosis (157)
Data (7985)
Decentralized trials (3)
Denatured (30)
Depression (165)
Dermatology (89)
Diabetes (589)
Diagnostics (7038)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (340)
Drug pricing (204)
Drug shortages (31)
Duchenne muscular dystrophy (285)
Earnings (93623)
Editorial (67)
Employer branding (21)
Employer resources (153)
Events (122682)
Executive appointments (1127)
FDA (20488)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (34)
Funding (1773)
Gene editing (242)
Generative AI (62)
Gene therapy (744)
GLP-1 (1063)
Government (4818)
Grass and pollen (7)
Guidances (411)
Healthcare (19464)
HIV (81)
Huntington's disease (57)
IgA nephropathy (97)
Immunology and inflammation (296)
Immuno-oncology (95)
Indications (191)
Infectious disease (3139)
Inflammatory bowel disease (221)
Inflation Reduction Act (14)
Influenza (141)
Intellectual property (292)
Interviews (324)
IPO (16815)
IRA (51)
Job creations (3724)
Job search strategy (1459)
JPM (58)
Kidney cancer (19)
Labor market (100)
Layoffs (574)
Leadership (39)
Legal (8103)
Liver cancer (101)
Longevity (33)
Lung cancer (769)
Lymphoma (432)
Machine learning (62)
Management (59)
Manufacturing (1068)
MASH (191)
Medical device (14065)
Medtech (14189)
Mergers & acquisitions (20496)
Metabolic disorders (1513)
mRNA (211)
Multiple sclerosis (190)
NASH (17)
Neurodegenerative disease (427)
Neuropsychiatric disorders (106)
Neuroscience (3372)
Neurotech (1)
NextGen: Class of 2026 (6670)
Non-profit (4652)
Now hiring (78)
Obesity (704)
Opinion (292)
Ovarian cancer (223)
Pain (256)
Pancreatic cancer (304)
Parkinson's disease (369)
Partnered (33)
Patents (596)
Patient recruitment (683)
Peanut (64)
People (60724)
Pharmaceutical (60)
Pharmacy benefit managers (32)
Phase 1 (22457)
Phase 2 (31598)
Phase 3 (23510)
Pipeline (8795)
Policy (318)
Postmarket research (2655)
Preclinical (9852)
Press Release (68)
Prostate cancer (308)
Psychedelics (54)
Radiopharmaceuticals (329)
Rare diseases (1098)
Real estate (6115)
Recruiting (70)
Regulatory (25820)
Reports (56)
Research institute (2535)
Resumes & cover letters (358)
Rett syndrome (39)
RNA editing (22)
RSV (89)
Schizophrenia (179)
Series A (300)
Series B (217)
Service/supplier (13)
Sickle cell disease (118)
Special edition (23)
Spinal muscular atrophy (174)
Sponsored (51)
Startups (3719)
State (2)
Stomach cancer (18)
Supply chain (129)
Tariffs (87)
The Weekly (66)
Vaccines (1104)
Venture capital (111)
Weight loss (454)
Women's health (127)
Worklife (20)
Date
Last 7 days (874)
Last 30 days (3449)
Last 365 days (30777)
2026 (12725)
2025 (30986)
2024 (35782)
2023 (40528)
2022 (51742)
2021 (56311)
2020 (54803)
2019 (47488)
2018 (35751)
2017 (32674)
2016 (32259)
2015 (38356)
2014 (32048)
2013 (27138)
2012 (29438)
2011 (30048)
2010 (28279)
Location
Africa (771)
Alabama (94)
Alaska (7)
Arizona (356)
Arkansas (15)
Asia (40557)
Australia (6644)
California (13454)
Canada (3792)
China (1371)
Colorado (574)
Connecticut (594)
Delaware (405)
Europe (89198)
Florida (2023)
Georgia (428)
Hawaii (3)
Idaho (62)
Illinois (1076)
India (92)
Indiana (608)
Iowa (24)
Japan (541)
Kansas (131)
Kentucky (52)
Louisiana (42)
Maine (76)
Maryland (1612)
Massachusetts (9680)
Michigan (363)
Minnesota (730)
Mississippi (6)
Missouri (146)
Montana (35)
Nebraska (29)
Nevada (143)
New Hampshire (91)
New Jersey (3646)
New Mexico (31)
New York (3543)
North Carolina (1821)
North Dakota (11)
Northern California (6726)
Ohio (405)
Oklahoma (24)
Oregon (42)
Pennsylvania (2699)
Puerto Rico (29)
Rhode Island (50)
South America (1142)
South Carolina (85)
South Dakota (2)
Southern California (5307)
Tennessee (215)
Texas (2138)
United States (47824)
Utah (398)
Vermont (1)
Virginia (328)
Washington D.C. (82)
Washington State (1076)
West Virginia (4)
Wisconsin (145)
Wyoming (2)
747,283 Results for "model n inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Model Medicines to Present End-to-End AI Drug Discovery Platform at Fierce Biotech Week 2026 in Boston
CEO Daniel Haders, PhD, joins the panel “Scaling AI Across the Biopharma Enterprise” to highlight progress in two lead programs, MDL-001 and MDL-4102. Model Medicines was previously named to Fierce Medtech’s Fierce 15.
May 5, 2026
·
1 min read
Press Releases
Model Medicines Granted First U.S. Patent related to MDL-001 in its Broad Antiviral Intellectual Property Portfolio
Model Medicines’ antiviral intellectual property portfolio encompasses 15 patent families covering novel compositions of matter, multi-scaffold Markush chemistry, formulations, and broad-spectrum methods of use across RNA and DNA viruses
April 16, 2026
·
1 min read
Press Releases
/C O R R E C T I O N -- Anixa Biosciences, Inc./
May 11, 2026
·
6 min read
Press Releases
InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer’s Disease Program
• Human Organoid Data Supports the Therapeutic Rationale for INM-901 Program Ahead of Human Clinical Trials • Consistent Anti-Inflammatory Effects Demonstrate Translation from Animal Models to Three-Dimensional Human Brain Tissue Systems
March 23, 2026
·
7 min read
Press Releases
TempraMed’s Independently Validated Payer ROI Model for Reimbursement Further Reinforced by a Scientific Publication Highlighting Clinical and Economic Rationale for VIVI Cap
Peer-reviewed case report by Prof. Andreas Pfützner demonstrates real-world insulin protection during extreme heat exposure and aligns with previously validated savings model
March 11, 2026
·
7 min read
Press Releases
INmune Bio Inc. Announces New Preclinical Data at AACR 2026 Demonstrating INB03 (XPro1595) Overcomes Resistance and Reduces Metastases in HER2-Positive Breast Cancer Models
April 16, 2026
·
5 min read
Press Releases
BrYet US, Inc. to Present ML-016 Preclinical Efficacy Data at AACR 2026
Preclinical studies show strong antitumor efficacy in lung metastasis models of triple-negative breast cancer and soft-tissue sarcoma
April 3, 2026
·
1 min read
Press Releases
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies
May 12, 2026
·
6 min read
Press Releases
Annovis CEO to Present on Multi-Protein Model of Alzheimer’s Disease at Fierce Biotech Week 2026
May 7, 2026
·
3 min read
gene editing
Gene therapy leaders aim to help more Baby KJs with novel regulatory models
As cell and gene therapy leaders gathered in Maryland to discuss accelerating clinical trials in children, one “cutting edge” session focused on the need to expedite more bespoke gene editing treatments like the one that saved young KJ Muldoon.
April 27, 2026
·
5 min read
·
Heather McKenzie
1 of 74,729
Next
